UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 571

Sortiert nach

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention

Journal of Nuclear Medicine, 2010-07, Vol.51 (7), p.1049-1058

2010

Volltextzugriff (PDF)

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

Pharmaceutics, 2020-06, Vol.12 (6), p.528

2020

Volltextzugriff (PDF)

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity

EJNMMI physics, 2020-02, Vol.7 (1), p.8-8, Article 8

2020

Volltextzugriff (PDF)

Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification

EJNMMI research, 2021-03, Vol.11 (1), p.27-27, Article 27

2021

Volltextzugriff (PDF)

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

PloS one, 2017-01, Vol.12 (1), p.e0170536-e0170536

2017

Volltextzugriff (PDF)

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?

EJNMMI radiopharmacy and chemistry, 2017-09, Vol.2 (1), p.11-11, Article 11

2017

Volltextzugriff (PDF)

Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules

EJNMMI research, 2021-05, Vol.11 (1), p.47-47, Article 47

2021

Volltextzugriff (PDF)

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2021-05, Vol.48 (5), p.1339-1350

2021

Volltextzugriff (PDF)

Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy

The Journal of nuclear medicine (1978), 2022-05, Vol.63 (5), p.761-769

2022

Volltextzugriff (PDF)

To go where no one has gone before: the necessity of radiobiology studies for exploration beyond the limits of the “Holy Gray” in radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2680-2682

2021

Volltextzugriff (PDF)

Generation of fluorescently labeled tracers – which features influence the translational potential?

EJNMMI radiopharmacy and chemistry, 2017-12, Vol.2 (1), p.15-15, Article 15

2017

Volltextzugriff (PDF)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

Pharmaceutics, 2019-10, Vol.11 (11), p.560

2019

Volltextzugriff (PDF)

Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

Endocrine-related cancer, 2010-03, Vol.17 (1), p.R53-R73

2010

Volltextzugriff (PDF)

Preclinical in vivo cancer, straightway to patients?

The quarterly journal of nuclear medicine and molecular imaging, 2017-06, Vol.61 (2), p.145

2017

Volltextzugriff (PDF)

Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1921

2024

Volltextzugriff (PDF)

[ 99m Tc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models

Molecules (Basel, Switzerland), 2020-07, Vol.25 (15), p.3418

2020

Volltextzugriff (PDF)

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

Cancers, 2021-03, Vol.13 (5), p.1100

2021

Volltextzugriff (PDF)

Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11

Journal of nuclear cardiology, 2021-12, Vol.28 (6), p.2506-2513

2021

Volltextzugriff (PDF)

Somatostatin Analogues: From Research to Clinical Practice

1, 2015

Volltextzugriff (PDF)

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment

International journal of molecular sciences, 2022-07, Vol.23 (14), p.8037

2022

Volltextzugriff (PDF)

Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors

Pharmaceuticals (Basel, Switzerland), 2022-09, Vol.15 (9), p.1155

2022

Volltextzugriff (PDF)

Short‐term dietary restriction and fasting precondition against ischemia reperfusion injury in mice

Aging cell, 2010-02, Vol.9 (1), p.40-53

2010

Volltextzugriff (PDF)

Review: Receptor Targeted Nuclear Imaging of Breast Cancer

International journal of molecular sciences, 2017-01, Vol.18 (2), p.260-260

2017

Volltextzugriff (PDF)

Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers

Royal Society open science, 2023-03, Vol.10 (3), p.220950-220950

2023

Volltextzugriff (PDF)

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [ 67 Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Molecules (Basel, Switzerland), 2017-11, Vol.22 (11), p.1950

2017

Volltextzugriff (PDF)

1 – 25 von 571

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(513)
Mit Volltextzugriff
(542)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(289)
Life Sciences & Biomedicine
(279)
Humans
(206)
Animals
(182)
Male
(137)
Radiology, Nuclear Medicine & Medical Imaging
(112)
Female
(91)
Rats
(82)
Mice
(71)
Oncology
(69)
Biological And Medical Sciences
(67)
Tissue Distribution
(67)
Medicine
(64)
Tumors
(64)
Nuclear Medicine
(63)
Octreotide - Analogs & Derivatives
(58)
Medicine & Public Health
(57)
Radiology
(56)
Imaging
(54)
Peptides
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity

Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?

Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy

To go where no one has gone before: the necessity of radiobiology studies for exploration beyond the limits of the “Holy Gray” in radionuclide therapy

Generation of fluorescently labeled tracers – which features influence the translational potential?

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

Preclinical in vivo cancer, straightway to patients?

Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile

[ 99m Tc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11

Somatostatin Analogues: From Research to Clinical Practice

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment

Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors

Short‐term dietary restriction and fasting precondition against ischemia reperfusion injury in mice

Review: Receptor Targeted Nuclear Imaging of Breast Cancer

Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [ 67 Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Suchergebnisse filtern